Immunomodulatory mediators IL-33, soluble ST2, IL-10, IFN-γ in the serum of patients with oral potentially malignant disorders and oral squamous cell carcinoma

BackgroundInterleukin-33 (IL-33) and its receptor Suppression of tumorigenicity 2 (ST2), along with IL-10 and IFN-γ, exert contrasting roles in tumor growth, immune evasion, and host defense. IL-33/ST2 signalling can either promote tumor progression or, in some contexts, enhance anti-tumor immunity....

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Swetha Acharya, Usha Hegde, Subba Rao Venkata Madhunapantula, Medha Karnik, Anirudh Balakrishna Acharya, Pushparaja Shetty
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2026-04-01
Reeks:	Frontiers in Oral Health
Onderwerpen:	interferon gamma (IFN-γ) interleukin-10 (IL-10) interleukin-33 (IL-33) interleukin-33 receptor (IL-33R) oral squamous cell carcinoma (OSCC) suppression of tumorigenicity 2 (ST2)
Online toegang:	https://www.frontiersin.org/articles/10.3389/froh.2026.1793916/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!